Late clinical and laboratory manifestations of thorotrast administration in cerebral arteriography. A follow-up study of thirty patients.
D000469:Alkaline Phosphatase / Q000097:blood; D001797:Blood Protein Electrophoresis; D001842:Bone and Bones / Q000528:radiation effects; D002533:Cerebral Angiography; D002869:Chromosome Aberrations / Q000528:radiation effects; D004912:Erythrocytes; D005500:Follow-Up Studies; D006801:Humans; D007621:Karyotyping; D007962:Leukocytes; D008111:Liver Function Tests; D011830:Radiation Effects; D011874:Radiometry; D012709:Serum Albumin / Q000032:analysis; D012712:Serum Globulins / Q000032:analysis; D013448:Sulfobromophthalein / Q000378:metabolism; D013911:Thorium Dioxide / Q000008:administration & dosage / Q000009:adverse effects*
D012709:Serum Albumin; D012712:Serum Globulins; D013448:Sulfobromophthalein; D013911:Thorium Dioxide; D000469:Alkaline Phosphatase